Current studies into retatritide peptide reveal notable potential for addressing weight and type 2 diabetes. The peptide, a dual agonist of GLP-1 and glucose-dependent insulinotropic polypeptide, seems to offer greater weight reduction and blood sugar regulation compared existing therapies. Additional patient studies are required to completely asse